GB0002095D0 — Device
Assigned to Novartis AG · Expires 2000-03-22 · 26y expired
What this patent protects
A device for dispensing a measured dose of liquid from an attached container which container has an elongate casing defining a dispensing cylinder, one end of the casing being adapted for mounting on the container. A plurality of dose indications are provided on the external surf…
USPTO Abstract
A device for dispensing a measured dose of liquid from an attached container which container has an elongate casing defining a dispensing cylinder, one end of the casing being adapted for mounting on the container. A plurality of dose indications are provided on the external surface of the casing so that a dose may be pre-selected by moving a dose setting collar along the casing. The collar has a stop engageable with a selected one of a multiplicity of recesses on the casing to secure the collar at the required position. A plunger having a piston co-operating with a cylinder defined by the casing is movable to lift the piston from said one end of the casing until the piston abuts the dose setting collar so charging the dispenser. Depression of the plunger to move the piston back to said one end dispenses the selected dose from an outlet port.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.